Stemcell Technologies Testing Smart Shippers

Could be used to transport temperature-sensitive products for research in areas such as cellular therapies, blood cancers and solid tumors.

Privately owned biotech company STEMCELL Technologies Inc. is testing the evo™ Smart Shipper and Cloud Based biologistex™ Cold Chain Management App from BioLife Solutions, Inc., developer, manufacturer and marketer of proprietary clinical-grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud-hosted biologistics cold chain management app for smart shippers.

A strategic distributor since 2008, Vancouver, British Columbia, Canada-based STEMCELL Technologies markets more than 2,000 products to the life science research community, including BioLife's BloodStor®, CryoStor® and HypoThermosol® biopreservation media products. Many of STEMCELL Technologies’ products, such as primary cells and apheresis collections, are time- and temperature-sensitive, requiring cold chain logistics to ensure biologic stability and usability by end users.

David Llewellyn, Vice President, Business Operations at STEMCELL Technologies, says, “We continually strive to provide more value to the research community and are very keen to complete the testing of the evo Smart Shipper. Our customers count on us to supply very high quality, temperature-sensitive materials for research. BioLife has been an excellent supplier and the biologistex cold chain logistics app could enable us to further improve the quality of our products and enhance our customer service."

Mike Rice, BioLife's President & CEO, says, "We are very pleased to expand our relationship with STEMCELL Technologies and to announce another customer testing program for the evo Smart Shipper and our SaaS cold chain logistics app."

Companies in this article
More in Pharmaceutical